What is H4CBD? Effects, risks & differences to CBD
|
Time to read 6 min
Free delivery on orders over €59 🚚
|
Time to read 6 min
The positive effects of CBD (cannabidiol) on well-being and health are now widely known. CBD is thus, alongside psychoactive THC, one of the most well-known and popular cannabinoids, valued primarily for its relaxing, anti-inflammatory, and anxiolytic properties, and with very few side effects.
Nevertheless, research in this area is constantly evolving. New cannabinoid variants are continually being discovered or developed and marketed. Currently, all eyes are on Hexahydrocannabinol, or H4CBD. But what exactly is behind this cumbersome name and strange abbreviation? Are we dealing with a true innovation with great new properties, or just a fleeting trend? Or is H4CBD perhaps even dangerous? In this blog post, we get to the bottom of the matter!
Table of Contents
H4CBD is currently generating a lot of public interest, but solid research on its effects and side effects is still lacking.
H4CBD is a synthetic product (derivative) created by hydrogenating CBD. This likely gives it a stronger effect on the endocannabinoid system in the human body.
The potential risks associated with H4CBD use (unclear side effects, possible addiction risk) are currently too high to justify its potential positive effects.
H4CBD, also known as Hexahydrocannabinol, is a chemically modified form of CBD. It is created through a process called hydrogenation, where hydrogen molecules are added to the original CBD molecule. This process changes the structure and potentially the effects of CBD. This is roughly comparable to the difference between THC (Tetrahydrocannabinol) and CBD (Cannabidiol). While one is, so to speak, the other's sibling, they have massively different effects.
While CBD (like THC) is a naturally occurring cannabinoid in the hemp plant, H4CBD is artificially produced. There is no plant or naturally occurring resource where H4CBD is present. It is a purely synthetic product.
Hydrogenation makes H4CBD more stable and potentially more effective than CBD, which is promoted as a major advantage by some manufacturers. At the same time, it is difficult to foresee what long-term effects the use of H4CBD might have, especially since research results are still lacking here.
Fundamentally, the modification in the CBD molecule can lead to the active ingredient interacting differently with the cannabinoid receptors in the body—especially with the CB1 and CB2 receptors of the endocannabinoid system.
CBD Oils from Hanfgeflüster
CBD and H4CBD differ not only in their chemical structure but also in their fundamental effects:
Property |
CBD |
H4CBD |
|---|---|---|
Naturally occurring |
Yes |
No (synthetically produced) |
Binding to CB1 receptors |
Low |
Stronger than CBD |
Binding to CB2 receptors |
Modulation |
Similar or stronger than CBD |
Anti-inflammatory effect |
Yes |
Potentially stronger |
Calming effect |
Yes |
Potentially more intense |
Availability |
Widely available, various forms of application |
Rarely available on the market |
Psychoactive effect |
No |
Presumed mild psychoactive effect |
Addiction potential |
None (psychological dependence possible) |
Could be physically addictive |
Many find the interaction with CB1 and CB2 receptors particularly interesting. While CBD hardly interacts with the CB1 receptor in the brain and only modulates the CB2 receptor, there are indications that H4CBD binds to this receptor, similar to THC. H4CBD can therefore have a mild psychoactive effect (quite different from CBD!), though significantly less pronounced than that of THC.
The data on the effects of H4CBD in research is still relatively scarce. However, due to H4CBD's interaction with the endocannabinoid system, the following possible effects can be deduced:
Stronger anti-inflammatory effect: Due to improved CB2 receptor binding, H4CBD could be more effective against inflammation than regular CBD.
Deeper relaxation: Some users report an even more intense calming effect compared to conventional CBD.
Potential pain reduction: Through interaction with CB1 and CB2 receptors, H4CBD could have an even better analgesic (pain-relieving) effect.
However, further research is needed to confirm these hypotheses. How safe the use of H4CBD is also remains unclear.
While CBD has very few side effects, which are also mild, synthetic cannabinoids like H4CBD can have unforeseen, possibly severe side effects.
Fatigue
Dizziness
Dry mouth
Interactions with medications
Psychoactive effect/high
Potential addiction
Since H4CBD is suspected to interact more strongly with the CB1 receptor, it can have a psychoactive effect - an effect that may or may not be desired. Due to its psychoactivity, there is also a general risk of addiction, which is not present with CBD. Whether more severe consequences (psychoses), as observed with THC, are possible has not yet been sufficiently researched.
There is often confusion regarding the various natural and synthetic cannabinoids on the market. Here is a brief overview:
CBD: A very low-side-effect, mild cannabinoid that occurs naturally in the cannabis plant. Its positive effects are extensively documented. (1)
H4CBD: A hydrogenated version of CBD, which may have stronger anti-inflammatory and relaxing properties than natural CBD, but probably brings with it stronger side effects.
THC: The best-known psychoactive cannabinoid responsible for the "high" effect of cannabis/marijuana.
HHC: A hydrogenated version of THC, with similar but milder psychoactive effects.
What a difference a few hydrogen atoms can make, right?
Basically, synthetic cannabinoids usually act more strongly than their natural variants. However, this often comes with stronger side effects and higher risks.
Unfortunately, the legislation regarding H4CBD in Germany is still rather a grey area. While CBD is legal in most countries, the situation for H4CBD has not yet been clarified. In Germany and the EU, it could be classified as a novel food or even as a synthetic cannabinoid, but the corresponding approvals are missing. However, since research into the effects and side effects of H4CBD is still in its infancy, we advise appropriate caution when using it.
The good news: For many applications, H4CBD is not needed. Instead, you can rely on the natural, gentle, and low-side-effect CBD variant and benefit from its diverse applications and positive effects. CBD helps with menstrual complaints, improves your sleep, and can even be used for pets.
Natural: CBD occurs naturally in the cannabis plant, whereas H4CBD is a synthetic derivative.
Better researched: The effects of CBD have been investigated in numerous studies (2), while there is hardly any scientific data on H4CBD yet.
Clearer legal situation: CBD is legal in many countries, while H4CBD often lies in a legal grey area.
Milder effect: Due to its enhanced receptor binding, H4CBD could have stronger effects (psychoactivity) and side effects (addiction, psychoses) than CBD.
Comprehensive quality control: CBD is subject to more comprehensive controls of quality and THC content than H4CBD. It is therefore generally classified as safer.
Interest in H4CBD is and remains unbroken. And indeed: Due to its hydrogenated structure, it is probably more stable than other cannabinoids and binds more strongly to the receptors in the body.
At the same time, this increases the risks that the use of H4CBD can entail. These range from stronger side effects than those known from CBD (dry mouth, digestive problems) to real dangers such as an unwanted psychoactive effect or possible addiction.
As long as no further information from research and long-term experience is available, we therefore advise caution when dealing with H4CBD. The good news: CBD is already in no way inferior to H4CBD. The benefits that many people hope for from H4CBD are already offered by high-quality CBD products - and that legally, with controlled quality and very few side effects.
Our customers' opinions:
Sources and Studies
(1) White C. M. (2019). A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential. Journal of clinical pharmacology, 59(7), 923–934.
(2) Mlost, J., Bryk, M., & Starowicz, K. (2020). Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. International journal of molecular sciences, 21(22), 8870.